Michele Barry, director of the Stanford Center for Innovation in Global Health, explains how this strain differs, why public risk outside the DRC remains low, and what a global response requires.
Source link
Michele Barry, director of the Stanford Center for Innovation in Global Health, explains how this strain differs, why public risk outside the DRC remains low, and what a global response requires.
Source link
